Record number:
925
Adverse Occurrence type:
MPHO Type:
Estimated frequency:
Most recent risk assessment (Council of Europe, 2022): Oesophageal, gastric, pancreatic, liver and biliary cancers diagnosed during donor procurement : These tumours are classified as unacceptable risk. Oesophageal, gastric, pancreatic, liver and biliary cancers in the donor history: Treated tumours of these kinds in the donor history are classified as high risk due to their aggressive behaviour. Risk may decrease for early stages after curative therapy, with recurrence-free time > 5 years and with increasing probability of cure, especially in cases of long-term survivors
Time to detection:
5 months
Alerting signals, symptoms, evidence of occurrence:
Reported to DTAC 1.5 months posttransplant (not reported which recipient was the first) - no alerting signals published
Demonstration of imputability or root cause:
DTAC (Disease Transmission Advisory Committee) classifies transmission as proven, no details reported in the paper
Keywords:
Suggest references:
aaa